Review: taking Klonopin and Risperidone together


Summary

Drug interactions are reported among people who take Klonopin and Risperidone together. This review analyzes the effectiveness and drug interactions between Klonopin and Risperidone. It is created by eHealthMe based on reports of 3,799 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Klonopin and Risperidone >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Klonopin

Klonopin has active ingredients of clonazepam. It is often used in stress and anxiety. (latest outcomes from Klonopin 34,034 users)

Risperidone

Risperidone has active ingredients of risperidone. It is often used in schizophrenia. (latest outcomes from Risperidone 16,390 users)

On Aug, 23, 2016

3,799 people who take Klonopin, Risperidone are studied.


Number of reports submitted per year:

Klonopin and Risperidone drug interactions.

Drug effectiveness over time:

Klonopin:
  • < 1 month: 0.0% - (0 of 9 people)
  • 1 - 6 months: 14.0% - (2 of 14 people)
  • 6 - 12 months: 40.0% - (2 of 5 people)
  • 1 - 2 years: 50.0% - (4 of 8 people)
  • 2 - 5 years: 33.0% - (5 of 15 people)
  • 5 - 10 years: 57.0% - (4 of 7 people)
  • 10+ years: 71.0% - (5 of 7 people)
  • not specified: 100.0% - (2 of 2 people)
Risperidone:
  • < 1 month: 0.0% - (0 of 13 people)
  • 1 - 6 months: 18.0% - (3 of 16 people)
  • 6 - 12 months: 0.0% - (0 of 5 people)
  • 1 - 2 years: 42.0% - (3 of 7 people)
  • 2 - 5 years: 40.0% - (4 of 10 people)
  • 5 - 10 years: 55.0% - (5 of 9 people)
  • 10+ years: 75.0% - (3 of 4 people)
  • not specified: 0.0% - (0 of 2 people)

Drug effectiveness by gender:

Klonopin:
  • female: 44.0% - (20 of 45 people)
  • male: 18.0% - (4 of 22 people)
Risperidone:
  • female: 23.0% - (10 of 43 people)
  • male: 34.0% - (8 of 23 people)

Drug effectiveness by age:

Klonopin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 3 people)
  • 20-29: 35.0% - (5 of 14 people)
  • 30-39: 31.0% - (7 of 22 people)
  • 40-49: 25.0% - (2 of 8 people)
  • 50-59: 58.0% - (10 of 17 people)
  • 60+: 0.0% - (0 of 3 people)
Risperidone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 4 people)
  • 20-29: 20.0% - (3 of 15 people)
  • 30-39: 35.0% - (7 of 20 people)
  • 40-49: 25.0% - (2 of 8 people)
  • 50-59: 37.0% - (6 of 16 people)
  • 60+: 0.0% - (0 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • type 2 diabetes mellitus
  • psychotic disorder
  • diabetes mellitus
  • insomnia
  • anxiety
  • mania
  • suicidal ideation
  • pancreatitis
  • self injurious behaviour
  • coma
1 - 6 months:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • neuropathy peripheral
  • obesity
  • hyperglycaemia
  • diabetic neuropathy
  • weight increased
  • diabetes mellitus inadequate control
  • blood cholesterol increased
  • blood triglycerides increased
6 - 12 months:
  • type 2 diabetes mellitus
  • obesity
  • pneumonia
  • atelectasis
  • blood cholesterol increased
  • blood triglycerides increased
  • diabetes mellitus inadequate control
  • neoplasm malignant
  • neoplasm progression
  • suicidal ideation
1 - 2 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • blood cholesterol increased
  • hyperlipidaemia
  • neuropathy peripheral
  • weight increased
  • hyperglycaemia
  • tardive dyskinesia
  • obesity
  • pancreatitis
2 - 5 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • neuropathy peripheral
  • blood triglycerides increased
  • diabetes mellitus inadequate control
  • weight increased
  • blood cholesterol increased
  • type 1 diabetes mellitus
  • hyperlipidaemia
  • diabetic neuropathy
5 - 10 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • tardive dyskinesia
  • diabetes mellitus inadequate control
  • diabetic neuropathy
  • movement disorder
  • coronary artery disease
  • multiple sclerosis
  • blood cholesterol increased
  • convulsion
10+ years:
  • type 2 diabetes mellitus
  • obesity
  • headache
  • abnormal weight gain
  • bacterial arthritis
  • hyperglycaemia
  • intermittent pyrexia
  • itching
  • laryngeal nerve damage
  • respiratory disorder
not specified:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • weight increased
  • anxiety
  • suicidal ideation
  • depression
  • insomnia
  • nausea
  • drug ineffective
  • dyspnoea

Most common drug interactions by gender *:

female:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • weight increased
  • anxiety
  • depression
  • pain
  • nausea
  • suicidal ideation
  • blood cholesterol increased
  • headache
male:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • weight increased
  • suicidal ideation
  • anxiety
  • drug ineffective
  • insomnia
  • depression
  • pneumonia
  • fatigue

Most common drug interactions by age *:

0-1:
  • diabetes mellitus
  • maternal drugs affecting foetus
  • pancreatitis
  • gastritis
  • nephrolithiasis
  • obstruction gastric
  • type 2 diabetes mellitus
  • urethral stenosis
  • weight increased
2-9:
  • abnormal behaviour
  • convulsion
  • agitation
  • drooling
  • drug ineffective
  • toxic epidermal necrolysis
  • diarrhoea
  • aggression
  • pyrexia
  • tardive dyskinesia
10-19:
  • weight increased
  • suicidal ideation
  • type 2 diabetes mellitus
  • abnormal behaviour
  • blood triglycerides increased
  • electrocardiogram qt prolonged
  • anxiety
  • depression
  • fatigue
  • aggression
20-29:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • insomnia
  • weight increased
  • suicidal ideation
  • aggression
  • convulsion
  • pancreatitis
  • suicide attempt
  • anger
30-39:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • weight increased
  • diabetes mellitus inadequate control
  • blood cholesterol increased
  • obesity
  • blood triglycerides increased
  • anxiety
  • hyperlipidaemia
  • depression
40-49:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • neuropathy peripheral
  • weight increased
  • diabetes mellitus inadequate control
  • diabetic neuropathy
  • hyperglycaemia
  • chest pain
  • anxiety
  • obesity
50-59:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • weight increased
  • pain
  • suicidal ideation
  • depression
  • anxiety
  • diabetic neuropathy
  • nausea
  • weight decreased
60+:
  • anxiety
  • asthenia
  • fall
  • dyspnoea
  • confusional state
  • pain
  • tremor
  • suicidal ideation
  • insomnia
  • pneumonia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Klonopin and Risperidone?

Can you answer these questions?

More questions for: Klonopin, Risperidone

You may be interested in these reviews

More reviews for: Klonopin, Risperidone

On eHealthMe, Klonopin (clonazepam) is often used to treat stress and anxiety. Risperidone (risperidone) is often used to treat schizophrenia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.